Place de l’imagerie fonctionnelle dans la définition des volumes cible en cancérologie pulmonaire

Aupérin, 2010, Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer, J Clin Oncol, 28, 2181, 10.1200/JCO.2009.26.2543 Thureau, 2011, Interest of FDG-PET for lung cancer radiotherapy, Cancer Radiother, 15, 504, 10.1016/j.canrad.2011.07.227 3 Yuan, 2007, A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III non-small cell lung cancer, Am J Clin Oncol, 30, 239, 10.1097/01.coc.0000256691.27796.24 Rosenzweig, 2007, Involved-field radiation therapy for inoperable non small-cell lung cancer, J Clin Oncol, 25, 5557, 10.1200/JCO.2007.13.2191 Belderbos, 2008, Report from the International Atomic Energy Agency (IAEA) consultants’ meeting on elective nodal irradiation in lung cancer: non-small-cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 72, 335, 10.1016/j.ijrobp.2008.04.081 Kimura, 2010, Int J Radiat Oncol Biol Phys, 77, 337, 10.1016/j.ijrobp.2009.05.039 De Ruysscher, 2010, European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer, J Clin Oncol, 28, 5301, 10.1200/JCO.2010.30.3271 Pieterman, 2000, Preoperative staging of non-small-cell lung cancer with positron-emission tomography, N Engl J Med, 343, 254, 10.1056/NEJM200007273430404 Vansteenkiste, 1998, Lymph node staging in non small cell lung cancer with FDGPET scan: a prospective study on 690 lymph node stations from 68 patients, J Clin Oncol, 16, 2142, 10.1200/JCO.1998.16.6.2142 Gould, 2003, Test performance of positron emission tomography and computed tomography for mediastinal staging with non-small cell lung cancer: a meta-analysis, Ann Intern Med, 139, 879, 10.7326/0003-4819-139-11-200311180-00013 Nomori, 2004, The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer, J Thorac Cardiovasc Surg, 127, 1087, 10.1016/j.jtcvs.2003.08.010 de Langen, 2006, The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis, Eur J Cardiothorac Surg, 29, 26, 10.1016/j.ejcts.2005.10.002 Peeters, 2016, Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: how to use E(B)US-NA information in addition to PET-CT for delineation?, Radiother Oncol, 10.1016/j.radonc.2016.05.023 Akthar, 2016, Limitations of PET/CT in the detection of occult N1 metastasis in clinical stage I(T1-2aN0) non-small cell lung cancer for staging prior to streotactic body radiotherapy, Technol Cancer Res Treat., 10.1177/1533034615624045 Nestle, 1999, (18F)-fluorodeoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis, Int J Radiat Oncol Biol Phys, 44, 593, 10.1016/S0360-3016(99)00061-9 Spratt, 2010, Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer, Clin Nucl Med, 35, 237, 10.1097/RLU.0b013e3181d18eb0 Steenbakkers, 2006, Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis, Int J Radiat Oncol Biol Phys, 64, 435, 10.1016/j.ijrobp.2005.06.034 Caldwell, 2001, Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion, Int J Radiat Oncol Biol Phys, 51, 923, 10.1016/S0360-3016(01)01722-9 Deniaud-Alexandre, 2005, Impact of computed tomography and (18F)-fluorodeoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 63, 1432, 10.1016/j.ijrobp.2005.05.016 Schimek-Jasch, 2015, A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: reducing the interobserver variability in multicentre clinical studies, Strahlenther Onkol, 191, 525, 10.1007/s00066-015-0812-8 Aoki, 2016, Impact of pretreatment whole-tumor perfusion computed tomography and 18F-fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy, J Radiat Res, 10.1093/jrr/rrw045 Konert, 2015, PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014, Radiother Oncol, 116, 27, 10.1016/j.radonc.2015.03.014 Doll, 2014, Influence of experience and qualification on PET-based target volume delineation. When there is no expert – ask your colleague, Strahlenther Onkol, 190, 555, 10.1007/s00066-014-0644-y MacManus, 2009, Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007, Radiother Oncol, 91, 85, 10.1016/j.radonc.2008.11.008 Hong, 2007, Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning, Int J Radiat Oncol Biol Phys, 67, 720, 10.1016/j.ijrobp.2006.09.039 Duhaylongsod, 1995, Detection of primary and recurrent lung cancer by means of (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), J Thorac Cardiovasc Surg, 110, 130, 10.1016/S0022-5223(05)80018-2 Vera, 2013, Does enhanced CT influence the biological GTV measurement on FDG-PET images?, Radiother Oncol, 108, 86, 10.1016/j.radonc.2013.03.024 Nestle, 2005, Comparison of different methods for delineation of (18F)-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer, J Nucl Med, 46, 1342 Thureau, 2013, Interobserver agreement of qualitative analysis and tumor delineation of (18F)-fluoromisonidazole and 3′-deoxy-3′-(18F)-fluorothymidine PET images in lung cancer, J Nucl Med, 54, 1543, 10.2967/jnumed.112.118083 Daisne, 2003, Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency, Radiother Oncol, 69, 237, 10.1016/j.radonc.2003.10.009 Black, 2004, Defining a radiotherapy target with positron emission tomography, Int J Radiat Oncol Biol Phys, 60, 1272, 10.1016/j.ijrobp.2004.06.254 Schaefer, 2016, Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation, Eur J Nucl Med Mol Imaging, 43, 911, 10.1007/s00259-015-3239-7 Bowen, 2012, Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective, Clin Transl Med, 1, 18, 10.1186/2001-1326-1-18 Riou, 2014, Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study, Radiat Oncol, 9, 127, 10.1186/1748-717X-9-127 Hapdey, 2014, Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients, Radiother Oncol, 112, 407, 10.1016/j.radonc.2014.08.005 Kong, 2005, High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study, Int J Radiat Oncol Biol Phys, 63, 324, 10.1016/j.ijrobp.2005.02.010 van Baardwijk, 2010, Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer, J Clin Oncol, 28, 1380, 10.1200/JCO.2009.24.7221 Bradley, 2015, Lancet Oncol, 16, 187, 10.1016/S1470-2045(14)71207-0 Bentzen, 2011, Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription, Semin Radiat Oncol, 21, 101, 10.1016/j.semradonc.2010.10.001 Clausen, 2014, Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study, Radiat Oncol, 9, 228, 10.1186/s13014-014-0228-0 Aerts, 2012, Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation, Lung Cancer, 75, 73, 10.1016/j.lungcan.2011.06.003 Calais, 2015, Areas of high (18F)-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer, J Nucl Med, 56, 196, 10.2967/jnumed.114.144253 Gao, 2015, (18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer, Int J Clin Exp Med, 8, 7561 van Elmpt, 2012, The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer, Radiother Oncol, 104, 67, 10.1016/j.radonc.2012.03.005 Horsman, 2012, Imaging hypoxia to improve radiotherapy outcome, Nat Rev Clin Oncol, 9, 674, 10.1038/nrclinonc.2012.171 Even, 2015, PET-based dose painting in non-small cell lung cancer: comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes, Radiother Oncol, 116, 281, 10.1016/j.radonc.2015.07.013 van Elmpt, 2016, Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion, Eur J Nucl Med Mol Imaging, 43, 240, 10.1007/s00259-015-3169-4 Sonke, 2010, Adaptive radiotherapy for lung cancer, Semin Radiat Oncol, 20, 94, 10.1016/j.semradonc.2009.11.003 Bibault, 2015, Radiothérapie adaptative du carcinome bronchique non à petites cellules, Cancer Radiother, 19, 458, 10.1016/j.canrad.2015.05.021 Edet-Sanson, 2012, Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC), Radiother Oncol, 102, 251, 10.1016/j.radonc.2011.07.023 Vera, 2014, FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2), Eur J Nucl Med Mol Imaging, 41, 1057, 10.1007/s00259-014-2687-9